| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.55e-04 | 55 | 7 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.54e-04 | 83 | 7 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 4.51e-04 | 1244 | 7 | 4 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 4.89e-04 | 1271 | 7 | 4 | GO:0000987 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 7.06e-04 | 560 | 7 | 3 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 7.28e-04 | 566 | 7 | 3 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 7.33e-04 | 1412 | 7 | 4 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 8.30e-04 | 1459 | 7 | 4 | GO:0000977 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.58e-03 | 739 | 7 | 3 | GO:0003682 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.71e-03 | 891 | 7 | 3 | GO:0008270 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.10e-03 | 320 | 7 | 2 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 5.29e-03 | 326 | 7 | 2 | GO:0001217 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 5.64e-03 | 337 | 7 | 2 | GO:0031625 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 6.15e-03 | 1189 | 7 | 3 | GO:0046914 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 6.34e-03 | 358 | 7 | 2 | GO:0044389 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 7.79e-03 | 398 | 7 | 2 | GO:0046982 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 8.52e-03 | 417 | 7 | 2 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.62e-02 | 582 | 7 | 2 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.63e-02 | 753 | 7 | 2 | GO:0008134 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 1.02e-04 | 40 | 8 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | learning or memory | 3.07e-04 | 373 | 8 | 3 | GO:0007611 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 4.01e-04 | 1053 | 8 | 4 | GO:0000122 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 4.41e-04 | 83 | 8 | 2 | GO:0048168 | |
| GeneOntologyBiologicalProcess | cognition | 4.44e-04 | 423 | 8 | 3 | GO:0050890 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.15e-03 | 1390 | 8 | 4 | GO:0045944 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.18e-03 | 1399 | 8 | 4 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.23e-03 | 1413 | 8 | 4 | GO:1902679 | |
| GeneOntologyBiologicalProcess | erythrocyte differentiation | 1.96e-03 | 176 | 8 | 2 | GO:0030218 | |
| GeneOntologyBiologicalProcess | erythrocyte homeostasis | 2.28e-03 | 190 | 8 | 2 | GO:0034101 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.45e-03 | 197 | 8 | 2 | GO:0030509 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.91e-03 | 215 | 8 | 2 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.91e-03 | 215 | 8 | 2 | GO:0071773 | |
| GeneOntologyBiologicalProcess | myeloid cell homeostasis | 3.60e-03 | 240 | 8 | 2 | GO:0002262 | |
| GeneOntologyBiologicalProcess | behavior | 3.82e-03 | 891 | 8 | 3 | GO:0007610 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 5.01e-03 | 284 | 8 | 2 | GO:0007626 | |
| GeneOntologyBiologicalProcess | regulation of synaptic plasticity | 5.32e-03 | 293 | 8 | 2 | GO:0048167 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | 5.96e-03 | 1043 | 8 | 3 | GO:0048871 | |
| GeneOntologyCellularComponent | chromatin | 8.26e-05 | 1480 | 8 | 5 | GO:0000785 | |
| GeneOntologyCellularComponent | euchromatin | 3.23e-04 | 72 | 8 | 2 | GO:0000791 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.16e-03 | 596 | 8 | 3 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 4.49e-03 | 272 | 8 | 2 | GO:0090575 | |
| MousePheno | absent mature ovarian follicles | 2.21e-04 | 40 | 8 | 2 | MP:0001132 | |
| MousePheno | abnormal brain development | 2.60e-04 | 638 | 8 | 4 | MP:0000913 | |
| MousePheno | increased T cell derived lymphoma incidence | 3.89e-04 | 53 | 8 | 2 | MP:0002024 | |
| MousePheno | increased thymus tumor incidence | 4.04e-04 | 54 | 8 | 2 | MP:0010365 | |
| MousePheno | abnormal midbrain development | 5.16e-04 | 61 | 8 | 2 | MP:0003864 | |
| MousePheno | absent corpus luteum | 6.04e-04 | 66 | 8 | 2 | MP:0001134 | |
| MousePheno | decreased pre-B cell number | 6.22e-04 | 67 | 8 | 2 | MP:0008209 | |
| MousePheno | abnormal definitive hematopoiesis | 6.43e-04 | 808 | 8 | 4 | MP:0002123 | |
| MousePheno | decreased mature ovarian follicle number | 7.38e-04 | 73 | 8 | 2 | MP:0002682 | |
| MousePheno | abnormal hemopoiesis | 7.42e-04 | 839 | 8 | 4 | MP:0013693 | |
| MousePheno | abnormal mature ovarian follicle morphology | 8.42e-04 | 78 | 8 | 2 | MP:0009364 | |
| MousePheno | postnatal growth retardation | 8.94e-04 | 881 | 8 | 4 | MP:0001732 | |
| MousePheno | abnormal postnatal growth | 9.98e-04 | 907 | 8 | 4 | MP:0001731 | |
| MousePheno | female infertility | 1.26e-03 | 410 | 8 | 3 | MP:0001926 | |
| MousePheno | abnormal pre-B cell morphology | 1.27e-03 | 96 | 8 | 2 | MP:0002403 | |
| MousePheno | abnormal blood cell morphology/development | 1.37e-03 | 986 | 8 | 4 | MP:0002429 | |
| MousePheno | decreased double-positive T cell number | 1.55e-03 | 106 | 8 | 2 | MP:0005092 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 1.73e-03 | 112 | 8 | 2 | MP:0004808 | |
| MousePheno | abnormal corpus luteum morphology | 1.85e-03 | 116 | 8 | 2 | MP:0002679 | |
| MousePheno | abnormal forebrain morphology | 1.87e-03 | 1072 | 8 | 4 | MP:0000783 | |
| MousePheno | abnormal ovarian folliculogenesis | 1.98e-03 | 120 | 8 | 2 | MP:0001130 | |
| Pubmed | Cotranscriptional exon skipping in the genotoxic stress response. | 2.78e-07 | 4 | 8 | 2 | 20972445 | |
| Pubmed | Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin. | 4.63e-07 | 5 | 8 | 2 | 18388149 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 5.30e-07 | 877 | 8 | 5 | 20211142 | |
| Pubmed | Bmp in podocytes is essential for normal glomerular capillary formation. | 4.21e-06 | 14 | 8 | 2 | 18272846 | |
| Pubmed | Bmp7 drives proximal tubule expansion and determines nephron number in the developing kidney. | 5.55e-06 | 16 | 8 | 2 | 35877077 | |
| Pubmed | 6.29e-06 | 17 | 8 | 2 | 28327634 | ||
| Pubmed | 7.07e-06 | 18 | 8 | 2 | 28763805 | ||
| Pubmed | Chronic otitis media is initiated by a bulla cavitation defect in the FBXO11 mouse model. | 8.78e-06 | 20 | 8 | 2 | 30898767 | |
| Pubmed | 1.01e-05 | 199 | 8 | 3 | 36688959 | ||
| Pubmed | 1.74e-05 | 28 | 8 | 2 | 27076431 | ||
| Pubmed | Zbtb20 is essential for the specification of CA1 field identity in the developing hippocampus. | 2.29e-05 | 32 | 8 | 2 | 20308569 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 2.97e-05 | 908 | 8 | 4 | 19274049 | |
| Pubmed | 3.24e-05 | 38 | 8 | 2 | 25613138 | ||
| Pubmed | 3.24e-05 | 38 | 8 | 2 | 29321139 | ||
| Pubmed | Pbx Regulates Patterning of the Cerebral Cortex in Progenitors and Postmitotic Neurons. | 3.60e-05 | 40 | 8 | 2 | 26671461 | |
| Pubmed | FGFR2 signaling enhances the SHH-BMP4 signaling axis in early ureter development. | 6.83e-05 | 55 | 8 | 2 | 35020897 | |
| Pubmed | 6.83e-05 | 55 | 8 | 2 | 34292881 | ||
| Pubmed | 1.75e-04 | 88 | 8 | 2 | 26318153 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.79e-04 | 89 | 8 | 2 | 22446626 | |
| Pubmed | 1.88e-04 | 91 | 8 | 2 | 21194568 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.01e-04 | 544 | 8 | 3 | 28473536 | |
| Interaction | SMARCA4 interactions | 3.28e-07 | 462 | 8 | 5 | int:SMARCA4 | |
| Interaction | CIITA interactions | 1.07e-06 | 55 | 8 | 3 | int:CIITA | |
| Interaction | WWP1 interactions | 1.82e-06 | 260 | 8 | 4 | int:WWP1 | |
| Interaction | RUNX1 interactions | 4.36e-06 | 324 | 8 | 4 | int:RUNX1 | |
| Interaction | ERCC8 interactions | 1.24e-05 | 124 | 8 | 3 | int:ERCC8 | |
| Interaction | MSC interactions | 1.44e-05 | 15 | 8 | 2 | int:MSC | |
| Interaction | NONO interactions | 3.50e-05 | 549 | 8 | 4 | int:NONO | |
| Interaction | TLE6 interactions | 4.12e-05 | 25 | 8 | 2 | int:TLE6 | |
| Interaction | PDLIM4 interactions | 4.82e-05 | 27 | 8 | 2 | int:PDLIM4 | |
| Interaction | CREBBP interactions | 4.92e-05 | 599 | 8 | 4 | int:CREBBP | |
| Interaction | TRIP4 interactions | 5.68e-05 | 206 | 8 | 3 | int:TRIP4 | |
| Interaction | CLINT1 interactions | 5.76e-05 | 207 | 8 | 3 | int:CLINT1 | |
| Interaction | POLR1A interactions | 6.90e-05 | 220 | 8 | 3 | int:POLR1A | |
| Interaction | CDK8 interactions | 7.09e-05 | 222 | 8 | 3 | int:CDK8 | |
| Interaction | RAI14 interactions | 7.28e-05 | 224 | 8 | 3 | int:RAI14 | |
| Interaction | EP300 interactions | 7.56e-05 | 1401 | 8 | 5 | int:EP300 | |
| Interaction | SAFB interactions | 9.39e-05 | 244 | 8 | 3 | int:SAFB | |
| Interaction | CDKN1C interactions | 1.12e-04 | 41 | 8 | 2 | int:CDKN1C | |
| Interaction | ERCC5 interactions | 2.41e-04 | 60 | 8 | 2 | int:ERCC5 | |
| Interaction | PHRF1 interactions | 2.49e-04 | 61 | 8 | 2 | int:PHRF1 | |
| Interaction | ZDHHC6 interactions | 2.58e-04 | 62 | 8 | 2 | int:ZDHHC6 | |
| Interaction | SUPT4H1 interactions | 3.01e-04 | 67 | 8 | 2 | int:SUPT4H1 | |
| Interaction | EYA3 interactions | 3.57e-04 | 73 | 8 | 2 | int:EYA3 | |
| Interaction | ZNF292 interactions | 3.57e-04 | 73 | 8 | 2 | int:ZNF292 | |
| Interaction | CTNNB1 interactions | 3.72e-04 | 1009 | 8 | 4 | int:CTNNB1 | |
| Interaction | MEN1 interactions | 4.01e-04 | 1029 | 8 | 4 | int:MEN1 | |
| Interaction | SUV39H2 interactions | 4.08e-04 | 78 | 8 | 2 | int:SUV39H2 | |
| Interaction | TAF15 interactions | 4.28e-04 | 408 | 8 | 3 | int:TAF15 | |
| Interaction | PPARGC1A interactions | 4.51e-04 | 82 | 8 | 2 | int:PPARGC1A | |
| Interaction | SOX7 interactions | 4.51e-04 | 82 | 8 | 2 | int:SOX7 | |
| Interaction | WAC interactions | 4.62e-04 | 83 | 8 | 2 | int:WAC | |
| Interaction | MAPK3 interactions | 4.69e-04 | 421 | 8 | 3 | int:MAPK3 | |
| Interaction | USF1 interactions | 4.84e-04 | 85 | 8 | 2 | int:USF1 | |
| Interaction | DDX17 interactions | 4.85e-04 | 426 | 8 | 3 | int:DDX17 | |
| Interaction | COPS5 interactions | 5.21e-04 | 1102 | 8 | 4 | int:COPS5 | |
| Interaction | PRMT5 interactions | 6.51e-04 | 471 | 8 | 3 | int:PRMT5 | |
| Interaction | ASB6 interactions | 6.56e-04 | 99 | 8 | 2 | int:ASB6 | |
| Interaction | CPNE2 interactions | 6.69e-04 | 100 | 8 | 2 | int:CPNE2 | |
| Interaction | MED6 interactions | 6.83e-04 | 101 | 8 | 2 | int:MED6 | |
| Interaction | SNRPA interactions | 6.96e-04 | 482 | 8 | 3 | int:SNRPA | |
| Interaction | MED29 interactions | 6.96e-04 | 102 | 8 | 2 | int:MED29 | |
| Interaction | DACH1 interactions | 7.24e-04 | 104 | 8 | 2 | int:DACH1 | |
| Interaction | PQBP1 interactions | 7.38e-04 | 105 | 8 | 2 | int:PQBP1 | |
| Interaction | PCNA interactions | 7.61e-04 | 497 | 8 | 3 | int:PCNA | |
| Interaction | MED26 interactions | 7.66e-04 | 107 | 8 | 2 | int:MED26 | |
| Interaction | PCF11 interactions | 8.24e-04 | 111 | 8 | 2 | int:PCF11 | |
| Interaction | CEBPA interactions | 8.30e-04 | 1245 | 8 | 4 | int:CEBPA | |
| Interaction | MAPRE1 interactions | 8.39e-04 | 514 | 8 | 3 | int:MAPRE1 | |
| Interaction | BRCA1 interactions | 8.40e-04 | 1249 | 8 | 4 | int:BRCA1 | |
| Interaction | NEURL4 interactions | 8.99e-04 | 116 | 8 | 2 | int:NEURL4 | |
| Interaction | SMAD4 interactions | 9.18e-04 | 530 | 8 | 3 | int:SMAD4 | |
| Interaction | HNRNPR interactions | 9.48e-04 | 536 | 8 | 3 | int:HNRNPR | |
| Interaction | MED16 interactions | 9.62e-04 | 120 | 8 | 2 | int:MED16 | |
| Interaction | MED8 interactions | 9.78e-04 | 121 | 8 | 2 | int:MED8 | |
| Interaction | NEDD4 interactions | 9.90e-04 | 544 | 8 | 3 | int:NEDD4 | |
| Interaction | ELK1 interactions | 1.04e-03 | 125 | 8 | 2 | int:ELK1 | |
| Interaction | SF3B3 interactions | 1.07e-03 | 558 | 8 | 3 | int:SF3B3 | |
| Interaction | PITX1 interactions | 1.08e-03 | 127 | 8 | 2 | int:PITX1 | |
| Interaction | SFPQ interactions | 1.09e-03 | 563 | 8 | 3 | int:SFPQ | |
| Interaction | CUL5 interactions | 1.12e-03 | 567 | 8 | 3 | int:CUL5 | |
| Interaction | DDX5 interactions | 1.12e-03 | 568 | 8 | 3 | int:DDX5 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 1.15e-03 | 298 | 8 | 2 | chr5q31 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 1.01e-05 | 150 | 8 | 3 | M8796 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.14e-05 | 193 | 8 | 3 | M6813 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 2.24e-05 | 196 | 8 | 3 | M4940 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.24e-05 | 196 | 8 | 3 | MM667 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN | 2.38e-05 | 200 | 8 | 3 | M5052 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 2.38e-05 | 200 | 8 | 3 | M9755 | |
| Coexpression | AMIT_SERUM_RESPONSE_40_MCF10A | 4.02e-05 | 32 | 8 | 2 | M11519 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_B_CELL_DN | 5.11e-05 | 36 | 8 | 2 | M48286 | |
| Coexpression | UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN | 5.11e-05 | 36 | 8 | 2 | M9162 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 6.32e-05 | 40 | 8 | 2 | M3649 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL | 1.07e-04 | 52 | 8 | 2 | M45780 | |
| Coexpression | NAGASHIMA_EGF_SIGNALING_UP | 1.29e-04 | 57 | 8 | 2 | M16311 | |
| Coexpression | AMIT_SERUM_RESPONSE_60_MCF10A | 1.34e-04 | 58 | 8 | 2 | M3447 | |
| Coexpression | TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP | 1.73e-04 | 66 | 8 | 2 | M2204 | |
| Coexpression | VANHARANTA_UTERINE_FIBROID_DN | 1.78e-04 | 67 | 8 | 2 | M13879 | |
| Coexpression | MALONEY_RESPONSE_TO_17AAG_DN | 2.36e-04 | 77 | 8 | 2 | M1858 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | 2.77e-04 | 1215 | 8 | 4 | M41122 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | 3.13e-04 | 477 | 8 | 3 | M40930 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS | 4.14e-04 | 102 | 8 | 2 | M43620 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | 4.71e-04 | 548 | 8 | 3 | M16859 | |
| Coexpression | SMIRNOV_RESPONSE_TO_IR_6HR_DN | 5.16e-04 | 114 | 8 | 2 | M2590 | |
| Coexpression | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP | 5.91e-04 | 122 | 8 | 2 | M18550 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 8.33e-04 | 145 | 8 | 2 | M11513 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP | 8.79e-04 | 149 | 8 | 2 | M8786 | |
| Coexpression | HALLMARK_DNA_REPAIR | 8.91e-04 | 150 | 8 | 2 | M5898 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 9.02e-04 | 685 | 8 | 3 | MM3782 | |
| Coexpression | GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP | 9.26e-04 | 153 | 8 | 2 | M8789 | |
| Coexpression | MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL | 9.26e-04 | 153 | 8 | 2 | M39171 | |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 1.00e-03 | 159 | 8 | 2 | M6502 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL | 1.01e-03 | 160 | 8 | 2 | M45779 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 1.09e-03 | 166 | 8 | 2 | M7722 | |
| Coexpression | GCNP_SHH_UP_EARLY.V1_DN | 1.10e-03 | 167 | 8 | 2 | M2638 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 1.14e-03 | 170 | 8 | 2 | M6697 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 1.17e-03 | 172 | 8 | 2 | M11585 | |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 1.33e-03 | 184 | 8 | 2 | M9219 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 1.35e-03 | 185 | 8 | 2 | M8792 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | 1.36e-03 | 790 | 8 | 3 | M12490 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN | 1.44e-03 | 191 | 8 | 2 | M4180 | |
| Coexpression | GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN | 1.44e-03 | 191 | 8 | 2 | M4935 | |
| Coexpression | GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN | 1.45e-03 | 192 | 8 | 2 | M4154 | |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP | 1.47e-03 | 193 | 8 | 2 | M4961 | |
| Coexpression | GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP | 1.47e-03 | 193 | 8 | 2 | M4177 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP | 1.48e-03 | 194 | 8 | 2 | M4958 | |
| Coexpression | GSE29618_BCELL_VS_MDC_UP | 1.48e-03 | 194 | 8 | 2 | M4943 | |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 1.48e-03 | 194 | 8 | 2 | M6493 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_UP | 1.50e-03 | 195 | 8 | 2 | M4936 | |
| Coexpression | GSE10325_CD4_TCELL_VS_BCELL_DN | 1.50e-03 | 195 | 8 | 2 | M3077 | |
| Coexpression | GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP | 1.50e-03 | 195 | 8 | 2 | M5875 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 1.51e-03 | 196 | 8 | 2 | M8135 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP | 1.51e-03 | 196 | 8 | 2 | M4954 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP | 1.51e-03 | 196 | 8 | 2 | M8503 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN | 1.53e-03 | 197 | 8 | 2 | M6075 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_UP | 1.53e-03 | 197 | 8 | 2 | M3081 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP | 1.53e-03 | 197 | 8 | 2 | M5867 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN | 1.54e-03 | 198 | 8 | 2 | M6224 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 1.54e-03 | 198 | 8 | 2 | M8036 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP | 1.54e-03 | 198 | 8 | 2 | M6112 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP | 1.54e-03 | 198 | 8 | 2 | M5850 | |
| Coexpression | GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN | 1.56e-03 | 199 | 8 | 2 | M3384 | |
| Coexpression | GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN | 1.56e-03 | 199 | 8 | 2 | M3569 | |
| Coexpression | GSE14308_TH2_VS_TH17_DN | 1.56e-03 | 199 | 8 | 2 | M3363 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN | 1.56e-03 | 199 | 8 | 2 | M4977 | |
| Coexpression | GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 1.56e-03 | 199 | 8 | 2 | M9751 | |
| Coexpression | GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP | 1.56e-03 | 199 | 8 | 2 | M7156 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP | 1.56e-03 | 199 | 8 | 2 | M7885 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 1.56e-03 | 199 | 8 | 2 | M5406 | |
| Coexpression | GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN | 1.57e-03 | 200 | 8 | 2 | M9668 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP | 1.57e-03 | 200 | 8 | 2 | M9895 | |
| Coexpression | GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN | 1.57e-03 | 200 | 8 | 2 | M9672 | |
| Coexpression | GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M5094 | |
| Coexpression | HALLMARK_TNFA_SIGNALING_VIA_NFKB | 1.57e-03 | 200 | 8 | 2 | M5890 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.57e-03 | 200 | 8 | 2 | M7529 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP | 1.57e-03 | 200 | 8 | 2 | M9742 | |
| Coexpression | GSE28237_EARLY_VS_LATE_GC_BCELL_DN | 1.57e-03 | 200 | 8 | 2 | M4894 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | 1.57e-03 | 200 | 8 | 2 | M7958 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.57e-03 | 200 | 8 | 2 | M6096 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 1.57e-03 | 200 | 8 | 2 | M6480 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN | 1.57e-03 | 200 | 8 | 2 | M7134 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN | 1.57e-03 | 200 | 8 | 2 | M4352 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN | 1.57e-03 | 200 | 8 | 2 | M7881 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP | 1.57e-03 | 200 | 8 | 2 | M7889 | |
| Coexpression | GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP | 1.57e-03 | 200 | 8 | 2 | M9622 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 1.57e-03 | 200 | 8 | 2 | M5956 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN | 1.57e-03 | 200 | 8 | 2 | M4994 | |
| Coexpression | GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN | 1.57e-03 | 200 | 8 | 2 | M3429 | |
| Coexpression | GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN | 1.57e-03 | 200 | 8 | 2 | M317 | |
| Coexpression | JIANG_MELANOMA_TRM4 | 1.62e-03 | 203 | 8 | 2 | M48968 | |
| Coexpression | PROVENZANI_METASTASIS_UP | 1.64e-03 | 204 | 8 | 2 | M4100 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 1.65e-03 | 205 | 8 | 2 | M39302 | |
| Coexpression | MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN | 1.68e-03 | 207 | 8 | 2 | M38977 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 1.78e-03 | 213 | 8 | 2 | M12176 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.88e-03 | 219 | 8 | 2 | M41199 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP | 1.97e-03 | 224 | 8 | 2 | M12383 | |
| Coexpression | MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN | 1.97e-03 | 224 | 8 | 2 | M38981 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL | 1.97e-03 | 224 | 8 | 2 | M41668 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 5.02e-05 | 29 | 8 | 2 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 5.37e-05 | 30 | 8 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 5.37e-05 | 30 | 8 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 1.70e-04 | 53 | 8 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 2.32e-04 | 62 | 8 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.68e-04 | 88 | 8 | 2 | gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_100 | 5.00e-04 | 91 | 8 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 2.63e-06 | 164 | 8 | 3 | 7766900740f67dbbe3c4d90fbfdcc1665cee6515 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-06 | 186 | 8 | 3 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 189 | 8 | 3 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 190 | 8 | 3 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 190 | 8 | 3 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 192 | 8 | 3 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 194 | 8 | 3 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 4.42e-06 | 195 | 8 | 3 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.49e-06 | 196 | 8 | 3 | 9a6e4eea19348a6e3379d3b872456ab6280cb74f | |
| ToppCell | ASK428-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.26e-05 | 41 | 8 | 2 | a72d926de3dc9e420b80764af88002e436517790 | |
| ToppCell | Myeloid-D_(Mast_cell)|World / shred on cell class and cell subclass (v4) | 2.29e-04 | 130 | 8 | 2 | 574e262eb4ed2d69c3da68be061cebac9fefc29e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.58e-04 | 138 | 8 | 2 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-04 | 140 | 8 | 2 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.70e-04 | 141 | 8 | 2 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.74e-04 | 142 | 8 | 2 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 143 | 8 | 2 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.81e-04 | 144 | 8 | 2 | fca32b38d23fa4d213e553b929604a2796e9a929 | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.85e-04 | 145 | 8 | 2 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.01e-04 | 149 | 8 | 2 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | Nasal_Brush-Epithelial-Club|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.05e-04 | 150 | 8 | 2 | c68645ffcffe524cf1d9736cf72a15b37ed8dc3d | |
| ToppCell | Nasal_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.05e-04 | 150 | 8 | 2 | d39d73a1de6a873292d48e469d9403f513045be3 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.17e-04 | 153 | 8 | 2 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.22e-04 | 154 | 8 | 2 | 874b1220337276489a89fcc9a39bc81ba6b68baf | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-04 | 155 | 8 | 2 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.26e-04 | 155 | 8 | 2 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-04 | 156 | 8 | 2 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-04 | 159 | 8 | 2 | c9e093d7c1dca83f6546adaf3d874929e2cea612 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-04 | 159 | 8 | 2 | 210ac7fa89514a84f38d9f42254e38fbc2bc5f42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.47e-04 | 160 | 8 | 2 | c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2 | |
| ToppCell | droplet-Heart-nan-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 161 | 8 | 2 | eb546d5065ac506405d240f9a1f55f2122d0c368 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.56e-04 | 162 | 8 | 2 | 88576622af741cf5f754e328bd6d53385ef53be6 | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 165 | 8 | 2 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 3.82e-04 | 168 | 8 | 2 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-04 | 171 | 8 | 2 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.96e-04 | 171 | 8 | 2 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 4.05e-04 | 173 | 8 | 2 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.15e-04 | 175 | 8 | 2 | 1b3510e9078eec7cfc5805043e435e9e5e0f0877 | |
| ToppCell | Basal-basal-3|World / Class top | 4.15e-04 | 175 | 8 | 2 | a0d7ced5204a9efbbb91ac99410a088f8ed2df0f | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.15e-04 | 175 | 8 | 2 | eaec7fda07a9537d067ca13b607a8ab201caa7c4 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 179 | 8 | 2 | d76a05f1fee7f2f7b7b7994d3622e96f02b49432 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 179 | 8 | 2 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 179 | 8 | 2 | 6be47c877250968a916c711ba0787eb7b4c5443d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.34e-04 | 179 | 8 | 2 | 40441de2d679733ecbf2145fabc3ed65a53310eb | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 179 | 8 | 2 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 179 | 8 | 2 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.44e-04 | 181 | 8 | 2 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.44e-04 | 181 | 8 | 2 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | (1)_B_cells-(1)_B_CD27pos|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.44e-04 | 181 | 8 | 2 | d2476956ca13f9234d7e77c3ee432dd54eebeac4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.48e-04 | 182 | 8 | 2 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 182 | 8 | 2 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 4.48e-04 | 182 | 8 | 2 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 182 | 8 | 2 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.48e-04 | 182 | 8 | 2 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 183 | 8 | 2 | 4060d979948e1dd7507977629a7fbdfa4ca65bb6 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 183 | 8 | 2 | 0d44a978221cf3f733704bf11863502805fba733 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.53e-04 | 183 | 8 | 2 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.58e-04 | 184 | 8 | 2 | 780d67f04fc795f614e077d8a5cf368542f6d99d | |
| ToppCell | Healthy/Control-B_memory|World / Disease group and Cell class | 4.58e-04 | 184 | 8 | 2 | 9e1879d86b535ede9b47deb0752e291f987a5d5e | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|Mesenchymal_cells / Lineage and Cell class | 4.58e-04 | 184 | 8 | 2 | 83987abaedc26e6da477bc70d65e10b1ab1aea60 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-04 | 185 | 8 | 2 | 7cf69717b88347833819c161ca89e751416f6c67 | |
| ToppCell | Monocytes-IL1B+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.63e-04 | 185 | 8 | 2 | cbe54b605f417a01b3b5d2ec75565ee3b5a9ba06 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 185 | 8 | 2 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 186 | 8 | 2 | 35f32fc2761435356c8f54b5bb2f026b8c070efe | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.68e-04 | 186 | 8 | 2 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.68e-04 | 186 | 8 | 2 | 76535681667c8afb884fa72b6edfee9e1e46335b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.68e-04 | 186 | 8 | 2 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 187 | 8 | 2 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 187 | 8 | 2 | ddfc2d1d9fcc3d8e4d3d015576bb17eebf44ada9 | |
| ToppCell | Healthy_donor-B_memory|World / disease group, cell group and cell class (v2) | 4.73e-04 | 187 | 8 | 2 | 4f68e3243071a4549c80aff8bff32c6ad892ee7f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-04 | 187 | 8 | 2 | d56664da336a580e9da2ea52622b5ce36fdafb1c | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.78e-04 | 188 | 8 | 2 | 18d16e3f095a109b6a690f46fe7fcd5674c3636b | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 188 | 8 | 2 | 63773854bf8430fb8229edb385b953a89833d08c | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.78e-04 | 188 | 8 | 2 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | Control-Lymphoid_B-B_memory|Control / Disease group, lineage and cell class | 4.78e-04 | 188 | 8 | 2 | ba4245de3bee29118abab57c4fce60b2007a189c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 188 | 8 | 2 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 188 | 8 | 2 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | Healthy/Control-B_memory|Healthy/Control / Disease group and Cell class | 4.78e-04 | 188 | 8 | 2 | 3aff07f77b2b15e7a30e47b30115178abe64474e | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-04 | 188 | 8 | 2 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.78e-04 | 188 | 8 | 2 | 9256c5f45c97df209bb9c322c3b557d4f726a333 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-04 | 188 | 8 | 2 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 189 | 8 | 2 | ce3fbaf9642785c8adf6edaeae20998bca558928 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.83e-04 | 189 | 8 | 2 | ebb5e069fdca7cf8ffac16a57572e92d2593c86a | |
| ToppCell | Control-Myeloid-MoAM1|Control / Disease group,lineage and cell class （2021.01.30） | 4.83e-04 | 189 | 8 | 2 | 55d5c2fb9e6ab556d42c83a1e985ee66e4cf9dba | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.83e-04 | 189 | 8 | 2 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.83e-04 | 189 | 8 | 2 | ac0203f17b481d608587113ea2de0f383b29ed27 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 189 | 8 | 2 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.83e-04 | 189 | 8 | 2 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.83e-04 | 189 | 8 | 2 | a59e4eaff430a443f9fa7edabe64e66a15b6bffb | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 190 | 8 | 2 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-04 | 190 | 8 | 2 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 4.89e-04 | 190 | 8 | 2 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-04 | 190 | 8 | 2 | 4b4fe93061c87605dddf5bec94fa07c749c722aa | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-04 | 190 | 8 | 2 | 5c8aa310886c64ee5dce4ba46a3dd178da549529 | |
| ToppCell | Severe-B_activate-7|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.89e-04 | 190 | 8 | 2 | 67e6c8a5a8724bdf2861fd76a711319dfc71d47a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 190 | 8 | 2 | db19c72d8c8053262b535068c5a9d4d696989cb1 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 4.89e-04 | 190 | 8 | 2 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 4.89e-04 | 190 | 8 | 2 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-04 | 190 | 8 | 2 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-04 | 190 | 8 | 2 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.89e-04 | 190 | 8 | 2 | 106862ef44fcaa0971c3ba0147d13eb08015ca77 | |
| Computational | Genes in the cancer module 197. | 8.05e-05 | 174 | 6 | 3 | MODULE_197 | |
| Computational | Genes in the cancer module 123. | 2.28e-04 | 247 | 6 | 3 | MODULE_123 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.14e-04 | 50 | 6 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.14e-04 | 50 | 6 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Computational | Genes in the cancer module 98. | 8.93e-04 | 393 | 6 | 3 | MODULE_98 | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; HL60; HG-U133A | 2.82e-07 | 184 | 8 | 4 | 1765_UP | |
| Drug | kt S | 1.29e-06 | 66 | 8 | 3 | CID006399216 | |
| Drug | Cosopt | 3.30e-06 | 341 | 8 | 4 | CID000003154 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.69e-05 | 155 | 8 | 3 | 1068_UP | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.56e-05 | 178 | 8 | 3 | 5779_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.60e-05 | 179 | 8 | 3 | 4541_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.60e-05 | 179 | 8 | 3 | 2656_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.64e-05 | 180 | 8 | 3 | 4641_UP | |
| Drug | Cantharidin [56-25-7]; Up 200; 20.4uM; HL60; HT_HG-U133A | 2.73e-05 | 182 | 8 | 3 | 3075_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.73e-05 | 182 | 8 | 3 | 6205_UP | |
| Drug | Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.78e-05 | 183 | 8 | 3 | 3190_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 2.82e-05 | 184 | 8 | 3 | 2696_UP | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.96e-05 | 187 | 8 | 3 | 6902_UP | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.01e-05 | 188 | 8 | 3 | 4405_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A | 3.06e-05 | 189 | 8 | 3 | 3072_UP | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HT_HG-U133A | 3.11e-05 | 190 | 8 | 3 | 4637_UP | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.11e-05 | 190 | 8 | 3 | 6253_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.16e-05 | 191 | 8 | 3 | 4791_UP | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.25e-05 | 193 | 8 | 3 | 4712_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 3.25e-05 | 193 | 8 | 3 | 1715_UP | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.31e-05 | 194 | 8 | 3 | 4429_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 194 | 8 | 3 | 7214_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; HL60; HG-U133A | 3.31e-05 | 194 | 8 | 3 | 1610_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.31e-05 | 194 | 8 | 3 | 1856_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.36e-05 | 195 | 8 | 3 | 1012_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A | 3.36e-05 | 195 | 8 | 3 | 1273_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.36e-05 | 195 | 8 | 3 | 4813_UP | |
| Drug | 17-AAG; Down 200; 1uM; SKMEL5; HG-U133A | 3.36e-05 | 195 | 8 | 3 | 505_DN | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 3.36e-05 | 195 | 8 | 3 | 2962_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 5860_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 5307_UP | |
| Drug | Hycanthone [3105-97-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 4630_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 1662_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; HL60; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 6139_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 3777_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 3436_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 5500_DN | |
| Drug | LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.46e-05 | 197 | 8 | 3 | 2676_UP | |
| Drug | Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 3472_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 1158_DN | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 5871_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.51e-05 | 198 | 8 | 3 | 1082_DN | |
| Drug | Amoxicillin [26787-78-0]; Down 200; 11uM; HL60; HT_HG-U133A | 3.57e-05 | 199 | 8 | 3 | 1265_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.57e-05 | 199 | 8 | 3 | 5931_UP | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 3.57e-05 | 199 | 8 | 3 | 2550_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.57e-05 | 199 | 8 | 3 | 2064_DN | |
| Drug | nickel sulfate | 3.73e-05 | 202 | 8 | 3 | CID000024586 | |
| Drug | EMCs | 6.03e-05 | 34 | 8 | 2 | CID005091655 | |
| Drug | Benzalkonium Compounds | 6.03e-05 | 34 | 8 | 2 | ctd:D001548 | |
| Drug | AC1Q5ZRG | 6.77e-05 | 36 | 8 | 2 | CID000004526 | |
| Drug | roscovitine | 8.37e-05 | 40 | 8 | 2 | ctd:C104586 | |
| Drug | lead chromate | 1.42e-04 | 52 | 8 | 2 | ctd:C031895 | |
| Drug | DAPH2 | 1.77e-04 | 58 | 8 | 2 | CID006711154 | |
| Drug | 1uyf | 1.77e-04 | 58 | 8 | 2 | CID000448972 | |
| Drug | triacsin C | 2.22e-04 | 65 | 8 | 2 | ctd:C034613 | |
| Drug | NOR-1 | 2.58e-04 | 70 | 8 | 2 | CID006399012 | |
| Drug | Phencyclidine | 3.89e-04 | 86 | 8 | 2 | ctd:D010622 | |
| Drug | Plant Oils | 5.30e-04 | 496 | 8 | 3 | ctd:D010938 | |
| Drug | valerate | 5.47e-04 | 102 | 8 | 2 | CID000007991 | |
| Drug | Sodium Dodecyl Sulfate | 5.90e-04 | 106 | 8 | 2 | ctd:D012967 | |
| Drug | AC1L1KKT | 6.59e-04 | 112 | 8 | 2 | CID000005542 | |
| Drug | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 6.70e-04 | 113 | 8 | 2 | ctd:C434003 | |
| Drug | Sp 1 (pharmaceutical) | 7.10e-04 | 548 | 8 | 3 | CID000099040 | |
| Drug | Thapsigargin | 7.16e-04 | 1353 | 8 | 4 | ctd:D019284 | |
| Drug | hydroxytamoxifen | 7.18e-04 | 117 | 8 | 2 | ctd:C475919 | |
| Drug | AC1L1K15 | 7.56e-04 | 120 | 8 | 2 | CID000005293 | |
| Drug | n-butoxyethanol | 8.41e-04 | 581 | 8 | 3 | ctd:C017096 | |
| Drug | Estriol | 8.59e-04 | 128 | 8 | 2 | ctd:D004964 | |
| Drug | Calcimycin | 9.13e-04 | 132 | 8 | 2 | ctd:D000001 | |
| Drug | AC1L71LQ | 1.01e-03 | 139 | 8 | 2 | CID000327967 | |
| Drug | E-PEG | 1.02e-03 | 621 | 8 | 3 | CID000003310 | |
| Drug | LY 171555 | 1.06e-03 | 142 | 8 | 2 | CID000001257 | |
| Drug | bromfenacoum | 1.13e-03 | 644 | 8 | 3 | ctd:C013418 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.21e-03 | 152 | 8 | 2 | 6807_UP | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.21e-03 | 152 | 8 | 2 | 6823_UP | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.24e-03 | 154 | 8 | 2 | 1520_UP | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.24e-03 | 154 | 8 | 2 | 2211_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.27e-03 | 156 | 8 | 2 | 1010_UP | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.29e-03 | 157 | 8 | 2 | 2651_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; HL60; HT_HG-U133A | 1.29e-03 | 157 | 8 | 2 | 1304_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; PC3; HT_HG-U133A | 1.29e-03 | 157 | 8 | 2 | 6764_UP | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.30e-03 | 158 | 8 | 2 | 2338_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; HL60; HT_HG-U133A | 1.32e-03 | 159 | 8 | 2 | 2192_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.32e-03 | 159 | 8 | 2 | 4325_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 1.32e-03 | 159 | 8 | 2 | 4328_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.34e-03 | 160 | 8 | 2 | 2210_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.34e-03 | 160 | 8 | 2 | 5275_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; HL60; HT_HG-U133A | 1.34e-03 | 160 | 8 | 2 | 2429_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.34e-03 | 160 | 8 | 2 | 4404_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.34e-03 | 160 | 8 | 2 | 2896_UP | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.35e-03 | 161 | 8 | 2 | 2227_UP | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.35e-03 | 161 | 8 | 2 | 2886_UP | |
| Drug | ON 01910 | 1.37e-03 | 162 | 8 | 2 | ctd:C507134 | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.37e-03 | 162 | 8 | 2 | 1486_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.37e-03 | 162 | 8 | 2 | 1655_UP | |
| Disease | Cocaine Abuse | 4.29e-06 | 127 | 8 | 3 | C0009171 | |
| Disease | Cocaine-Related Disorders | 4.30e-04 | 117 | 8 | 2 | C0236736 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 5.38e-04 | 131 | 8 | 2 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 5.38e-04 | 131 | 8 | 2 | C4552091 | |
| Disease | Juvenile arthritis | 5.38e-04 | 131 | 8 | 2 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 5.38e-04 | 131 | 8 | 2 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 5.71e-04 | 135 | 8 | 2 | C0087031 | |
| Disease | Cocaine Dependence | 6.06e-04 | 139 | 8 | 2 | C0600427 | |
| Disease | Prostatic Neoplasms | 1.12e-02 | 616 | 8 | 2 | C0033578 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APPSYPPTSYSSTQP | 186 | Q01844 | |
| YPQSPKTTKPPYPGS | 301 | Q96T17 | |
| TSYPSPATTSYPSPV | 456 | P18146 | |
| YYKPSSPPTPTTPGF | 121 | P43354 | |
| PPSYSVLYPSSDPKS | 581 | Q8N3V7 | |
| SPYPPSPASSTYPNS | 191 | Q99717 | |
| PSAKTPSSTYPAPFY | 201 | P15923 | |
| QSPSYSPTSPSYSPT | 1611 | P24928 | |
| SPTSPSYSPTSPSYS | 1616 | P24928 | |
| PTSPNYSPTSPSYSP | 1631 | P24928 | |
| PSYSPTSPSYSPTSP | 1641 | P24928 | |
| TSPSYSPTSPSYSPT | 1646 | P24928 | |
| SPTSPSYSPTSPSYS | 1651 | P24928 | |
| SYSPTSPSYSPTSPS | 1656 | P24928 | |
| SPSYSPTSPSYSPTS | 1661 | P24928 | |
| PTSPSYSPTSPSYSP | 1666 | P24928 | |
| PSYSPTSPSYSPTSP | 1676 | P24928 | |
| TSPSYSPTSPSYSPT | 1681 | P24928 | |
| SPTSPSYSPTSPSYS | 1686 | P24928 | |
| SYSPTSPSYSPTSPS | 1691 | P24928 | |
| SPSYSPTSPSYSPTS | 1696 | P24928 | |
| PTSPSYSPTSPSYSP | 1701 | P24928 | |
| PSYSPTSPSYSPTSP | 1711 | P24928 | |
| TSPSYSPTSPSYSPT | 1716 | P24928 | |
| SPTSPSYSPTSPSYS | 1721 | P24928 | |
| SYSPTSPSYSPTSPS | 1726 | P24928 | |
| SPSYSPTSPSYSPTS | 1731 | P24928 | |
| PTSPSYSPTSPNYSP | 1736 | P24928 | |
| PNYSPTSPNYTPTSP | 1746 | P24928 | |
| TSPNYTPTSPSYSPT | 1751 | P24928 | |
| TPTSPSYSPTSPSYS | 1756 | P24928 | |
| SPSYSPTSPNYTPTS | 1766 | P24928 | |
| PTSPNYTPTSPNYSP | 1771 | P24928 | |
| PNYSPTSPSYSPTSP | 1781 | P24928 | |
| TSPSYSPTSPSYSPT | 1786 | P24928 | |
| SPTSPSYSPTSPSYS | 1791 | P24928 | |
| PTYTPSSPSYSPSSP | 1816 | P24928 | |
| SPSSPSYSPASPKYT | 1826 | P24928 | |
| SYSPASPKYTPTSPS | 1831 | P24928 | |
| SPKYTPTSPSYSPSS | 1836 | P24928 | |
| PTSPSYSPSSPEYTP | 1841 | P24928 | |
| YSPSSPEYTPTSPKY | 1846 | P24928 | |
| PEYTPTSPKYSPTSP | 1851 | P24928 | |
| TSPKYSPTSPKYSPT | 1856 | P24928 | |
| SPTSPKYSPTSPKYS | 1861 | P24928 | |
| KYSPTSPKYSPTSPT | 1866 | P24928 | |
| SPKYSPTSPTYSPTT | 1871 | P24928 | |
| PTSPTYSPTTPKYSP | 1876 | P24928 | |
| YSPTTPKYSPTSPTY | 1881 | P24928 | |
| PKYSPTSPTYSPTSP | 1886 | P24928 | |
| TSPTYSPTSPVYTPT | 1891 | P24928 | |
| SPTSPVYTPTSPKYS | 1896 | P24928 | |
| VYTPTSPKYSPTSPT | 1901 | P24928 | |
| SPKYSPTSPTYSPTS | 1906 | P24928 | |
| PTSPTYSPTSPKYSP | 1911 | P24928 | |
| YSPTSPKYSPTSPTY | 1916 | P24928 | |
| PKYSPTSPTYSPTSP | 1921 | P24928 |